← The Wire
CDNANasdaq
CareDx, Inc.
Services-Medical Laboratories · DE · CIK 1217234
CareDx provides precision medicine solutions, including molecular testing, for transplant patients to improve outcomes and organ health
red 8-K · 90d
$1.19B
Market cap
$29.28
Last close
+1.6%
1D
+16.9%
5D
498K
Volume
Price · last 39 sessions+39.7%
May 4L $19.97 · H $29.28Jun 29
206
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 15, 2026DEFA14ADEFA14AJun 5, 202610-Q10-QApr 28, 20268-KMaterial Agreement · Results of OperationsApr 28, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-K/AExecutive ChangeApr 23, 20268-KMaterial Agreement · Results of OperationsApr 16, 20268-K/AExecutive Change · Results of OperationsFeb 25, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 24, 20268-KResults of OperationsJan 12, 20268-KCompany UpdateDec 18, 20258-KBylaw AmendmentDec 15, 202510-Q10-QNov 4, 20258-KResults of Operations · Reg FD DisclosureNov 4, 20258-KExecutive ChangeOct 24, 202510-Q10-QAug 6, 20258-KExecutive Change · Results of OperationsAug 6, 20258-KExecutive Change · Shareholder VoteJun 12, 20258-KReg FD Disclosure · Company UpdateJun 3, 202510-Q10-QApr 30, 20258-KResults of OperationsApr 30, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KExecutive ChangeMar 28, 202510-K10-KFeb 28, 20258-KResults of Operations · Reg FD DisclosureFeb 26, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KExecutive ChangeJan 8, 202510-Q10-QNov 4, 20248-KResults of OperationsNov 4, 20248-KResults of Operations · Reg FD DisclosureOct 15, 20248-KCompany UpdateOct 8, 20248-KExecutive ChangeOct 4, 20248-KExecutive Change · Company UpdateSep 12, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 31, 20248-KShareholder VoteJun 18, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KExecutive Change · Company UpdateApr 16, 20248-KExecutive Change · Company UpdateMar 11, 202410-K10-KFeb 28, 20248-KResults of Operations · Reg FD DisclosureFeb 28, 2024SC 13GSC 13GFeb 12, 2024SC 13GSC 13GFeb 5, 20248-KResults of Operations · Reg FD DisclosureJan 9, 20248-KExecutive ChangeDec 22, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KExecutive Change · Reg FD DisclosureNov 1, 20238-KExecutive ChangeSep 26, 20238-KCompany UpdateSep 25, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KBylaw Amendment · Shareholder VoteJun 20, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial AgreementApr 3, 20238-KBylaw AmendmentMar 28, 2023SC 13GSC 13GMar 13, 20238-KReg FD DisclosureMar 13, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 27, 2023SC 13GSC 13GFeb 15, 2023SC 13GSC 13GFeb 14, 20238-KResults of Operations · Reg FD DisclosureJan 9, 20238-KReg FD DisclosureDec 6, 20228-KExecutive ChangeNov 23, 20228-KResults of OperationsNov 3, 202210-Q10-QNov 3, 20228-KExecutive ChangeSep 7, 20228-KExecutive ChangeSep 1, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 2022
Insider Activity
In the 90 days to Feb 3, 2026: 2 sold $899K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 2026 | Novack Jeffrey AdamSecretary and General Counsel | Sell | 4,441 | $20.56 | $91K |
| Jan 22, 2026 | Hanna John Walter JrPresident and CEO | Sell | 19,280 | $21.16 | $408K |
| Jan 21, 2026 | Hanna John Walter JrPresident and CEO | Sell | 200 | $21.00 | $4K |
| Jan 15, 2026 | Hanna John Walter JrPresident and CEO | Sell | 10,156 | $21.05 | $214K |
| Dec 4, 2025 | Novack Jeffrey AdamSecretary and General Counsel | Sell | 7,007 | $19.15 | $134K |
| Dec 4, 2025 | Novack Jeffrey AdamSecretary and General Counsel | Sell | 286 | $19.75 | $6K |
| Nov 7, 2025 | Novack Jeffrey AdamSecretary and General Counsel | Sell | 2,688 | $15.52 | $42K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance